Takada K, Kashiwagi S, Nishikawa M, Kochi A, et al. Clinical characteristics and prognostic impact of HER2-ultralow breast cancer and tumor-infiltrating lymphocytes (TILs). BMC Cancer 2025 Nov 28. doi: 10.1186/s12885-025-15255.
PMID: 41316049